Business News

NATCO Pharma’s Visakhapatnam unit gets Form 483 with 4 observations from US FDA

FinSiddhi

NATCO Pharma said that the U.S. Food and Drug Administration (US FDA) has issued a Form 483 with four observations post an inspection to the company’s manufacturing plant at Visakhapatnam.
Read more at the source

Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.

Related Posts

In 1985, a Colorado hairdresser began rescuing entire beaver families; she later relocated more than 1,000 to streams where their dams could help rebuild wetlands

Sherri Tippie, a dedicated hairdresser turned conservationist, began her mission to rescue beaver families from extermination by learning trapping techniques. By founding a nonprofit organization, she has successfully relocated more than a thousand beavers, playing a crucial role in wetland restoration. Beaver dams not only filter water effectively but also help prevent floods, showcasing the…